Mechanisms of immune checkpoint inhibitors for treating hepatocellular carcinoma (IMAGE)

Cactus Communications

Mechanisms of immune checkpoint inhibitors for treating hepatocellular carcinoma

Caption

Patients diagnosed with hepatocellular carcinoma have poor survival rates and few effective options for therapy. In this review article, researchers from China have summarized the latest findings on current HCC immunotherapies and those under development.

Credit

Chinese Medical Journal

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.